| Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group SC Reshmi, RC Harvey, KG Roberts, E Stonerock, A Smith, H Jenkins, ... Blood, The Journal of the American Society of Hematology 129 (25), 3352-3361, 2017 | 302 | 2017 |
| Ph-like acute lymphoblastic leukemia TH Tran, ML Loh Hematology 2014, the American Society of Hematology Education Program Book …, 2016 | 98 | 2016 |
| High mortality among hospital-acquired COVID-19 infection in patients with cancer: a multicentre observational cohort study A Elkrief, A Desilets, N Papneja, L Cvetkovic, C Groleau, YA Lakehal, ... European Journal of Cancer 139, 181-187, 2020 | 83 | 2020 |
| The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities TH Tran, SP Hunger Seminars in cancer biology 84, 144-152, 2022 | 77 | 2022 |
| Molecular profiling of hard-to-treat childhood and adolescent cancers F Khater, S Vairy, S Langlois, S Dumoucel, T Sontag, P St-Onge, ... JAMA network open 2 (4), e192906-e192906, 2019 | 49 | 2019 |
| IKZF1 alterations in acute lymphoblastic leukemia: the good, the bad and the ugly S Vairy, TH Tran Blood Reviews 44, 100677, 2020 | 45 | 2020 |
| Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia TH Tran, MH Harris, JV Nguyen, TM Blonquist, KE Stevenson, ... Blood Advances 2 (5), 529-533, 2018 | 44 | 2018 |
| Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001 TH Tran, S Langlois, C Meloche, M Caron, P Saint-Onge, A Rouette, ... Blood advances 6 (4), 1329-1341, 2022 | 43 | 2022 |
| Precision medicine in pediatric oncology: translating genomic discoveries into optimized therapies TH Tran, AT Shah, ML Loh Clinical Cancer Research 23 (18), 5329-5338, 2017 | 33 | 2017 |
| Philadelphia chromosome-like acute lymphoblastic leukemia: a review of the genetic basis, clinical features, and therapeutic options M Khan, R Siddiqi, TH Tran Seminars in hematology 55 (4), 235-241, 2018 | 28 | 2018 |
| Salmonella enterica serotype Typhi infections in a Canadian pediatric hospital: a retrospective case series JL Comeau, TH Tran, DL Moore, CM Phi, C Quach Canadian Medical Association Open Access Journal 1 (1), E56-E61, 2013 | 24 | 2013 |
| Cryptic recurrent ACIN1‐NUTM1 fusions in non‐KMT2A‐rearranged infant acute lymphoblastic leukemia T Pincez, JR Landry, M Roussy, L Jouan, M Bilodeau, L Laramée, ... Genes, Chromosomes and Cancer 59 (2), 125-130, 2020 | 19 | 2020 |
| HLA alleles associated with asparaginase hypersensitivity in childhood ALL: a report from the DFCI Consortium V Gagné, P St-Onge, P Beaulieu, C Laverdière, JM Leclerc, TH Tran, ... Pharmacogenomics 21 (8), 541-547, 2020 | 13 | 2020 |
| A novel AGGF1-PDGFRb fusion in pediatric T-cell acute lymphoblastic leukemia MS Zabriskie, O Antelope, AR Verma, LR Draper, CA Eide, AD Pomicter, ... Haematologica 103 (2), e87, 2018 | 13 | 2018 |
| Lack of treatment-related mortality definitions in clinical trials of children, adolescents and young adults with lymphomas, solid tumors and brain tumors: a systematic review TH Tran, M Lee, S Alexander, P Gibson, U Bartels, DL Johnston, ... BMC cancer 14, 1-5, 2014 | 13 | 2014 |
| Cutaneous histiocytoses TH Tran, E Pope, S Weitzman Rook's Textbook of Dermatology, Ninth Edition, 1-35, 2016 | 12 | 2016 |
| Clinical screening for Ph-like ALL and the developing role of TKIs TH Tran, SK Tasian Hematology 2022 (1), 594-602, 2022 | 11 | 2022 |
| Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre … SP Hunger, TH Tran, V Saha, M Devidas, MG Valsecchi, ... The Lancet Haematology 10 (7), e510-e520, 2023 | 10 | 2023 |
| Feasibility of oncology clinical trial‐embedded evaluation of social determinants of health R Aziz‐Bose, DJ Zheng, PJ Umaretiya, L Ilcisin, K Stevenson, V Koch, ... Pediatric Blood & Cancer 69 (11), e29933, 2022 | 9 | 2022 |
| Repurposing alpelisib, an anti‐cancer drug, for the treatment of severe TIE2‐mutated venous malformations: preliminary pharmacokinetics and pharmacodynamic data A Remy, TH Tran, J Dubois, P Gavra, C Lapointe, R Winikoff, GB Facundo, ... Pediatric Blood & Cancer 69 (10), e29897, 2022 | 9 | 2022 |
daniel sinnettUniversité de Montreal/CHU Sainte-Justine在 umontreal.ca 的电子邮件经过验证
